Traditional Chinese medicine composition for treating pelvic inflammatory disease and preparation method thereof

Abstract

The invention relates to a traditional Chinese medicine composition for treating pelvic inflammatory disease and a preparation method thereof. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicines in parts by weight and through the processes of water extraction and alcohol extraction: 10-50 parts of lonicera japonica, 10-40 parts of herba epimedii, 10-50 parts of safflower, 10-40 parts of radix bupleuri, 10-35 parts of mint, 10-50 parts of leonurus japonicus, 10-50 parts of lily, 10-50 parts of houttuynia cordata, 10-45 parts of gypsum, 10-45 parts of peach tree bark, 10-40 parts of rhizoma atractylodis, 10-40 parts of myrrh, 10-45 parts of schisandra chinensis, 10-40 parts of cortex acanthopanacis, 5-30 parts of herba asari, 5-30 parts of coptis chinensis, 10-40 parts of radix paeoniae rubra, 10-40 parts of liquorice, 5-20 parts of erycibe obtusifolia, 10-70 parts of ochre, 20-70 parts of rhizoma kaempferiae, 20-70 parts of common gendarussa herb, 15-60 parts of daphne genkwa and 10-60 parts of rhizoma anemones raddeanae. Pharmacodynamic tests indicate that the traditional Chinese medicine composition provided by the invention has obvious functions of increasing the blood flow volume of peripheral vessels, resisting inflammation and relieving pain.

Description

technical field [0001] The invention relates to the field of medical inventions, in particular to a traditional Chinese medicine composition for treating pelvic inflammatory disease and a preparation method thereof. Background technique [0002] Pelvic inflammatory disease refers to the inflammation of the female internal genitalia and its surrounding connective tissue and pelvic peritoneum. It is clinically manifested as acute and chronic. Inflammation can be limited to one part, or several parts can be affected at the same time. Clinically, lower abdominal pain, increased leucorrhea, menstrual disorders, infertility, and lumbosacral pain are the main features. It is a common and frequently-occurring disease that seriously endangers women's health. It is easy to relapse and difficult to cure. If the pelvic inflammatory disease is severe, it may develop into chronic peritonitis, sepsis, or even toxic shock. If it is not completely cured in the acute stage, it will turn into ...

AI Technical Summary

Problems solved by technology

Inflammation can be limited to one part, or several parts can be affected at the same time. Clinically, lower abdominal pain, increased leucorrhea, menstrual disorders, infertility, and lumbosacral pain are the main features. It is a common and frequently-occurring disease that seriously endangers women's health. It is easy to relapse and difficult to cure. If the pelvic inflammatory disease is severe, it may develop into chronic peritonitis, sepsis, or even toxic shock. If it is not completely cured in the acute stage, it will turn into chronic pelvic inflammatory disease. It is more harmful, and the result is a series of family and social problems such as long-term chronic pelvic pain, infertility or ectopic pregnancy. Due to the difficulty in the treatment of chronic pelvic inflammatory disease, it is difficult to comprehensively treat chronic pelvic inflammatory disease. Therefore, the existing drugs have a low inhibitory effect on chronic pelvic inflammatory disease, and the clinical treatment effect is not outstanding. It is still difficult for the majority of patients with chronic pelvic inflammatory disease to get rid of the trouble of chronic pelvic inflammatory disease

At present, western medicine is the main clinical treatment, but the side effects of western medicine are relatively large. Therefore, it is a difficult problem for developers to solve chronic pelvic inflammatory disease with fast onset of Chinese medicine.

Images